Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 38.2633.6826.0334.4025.13

What is the latest EV/EBIT ratio of TORRENT PHARMACEUTICALS ?

The latest EV/EBIT ratio of TORRENT PHARMACEUTICALS is 38.26 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202538.26
Mar202433.68
Mar202326.03
Mar202234.40
Mar202125.13

How is EV/EBIT of TORRENT PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 38.26
13.60
Mar2024 33.68
29.39
Mar2023 26.03
-24.33
Mar2022 34.4
36.89
Mar2021 25.13 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/EBIT ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹140,683.0 Cr 3.7% -4.9% 26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics
MANKIND PHARMA ₹85,816.7 Cr 3% -3.9% -15.4% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

3.7%

-4.9%

26%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses